You need to enable JavaScript to run this app.
FDA offers guidance on minor label changes for OTC drugs
Regulatory News
Emily Hayes
Advertising, Promotion and Labeling
OTC
Pharmaceuticals
United States
Regulatory NewsEmily Hayes
Advertising, Promotion and LabelingOTCPharmaceuticalsUnited StatesRegulatory NewsEmily HayesAdvertising, Promotion and LabelingOTCPharmaceuticalsUnited States